ScholarIQanswers from OpenAlex & ORCID
Linda T. Vahdat
ResearcherPublications, citations & collaboration network
Linda T. Vahdat is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Linda T. Vahdat have?
ScholarIQindexed works
Linda T. Vahdat has 485 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Linda T. Vahdat have?
ScholarIQcitation count
Linda T. Vahdat has 19,167 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Linda T. Vahdat?
ScholarIQh-index
Linda T. Vahdat has an h-index of 66 in OpenAlex.
What is the i10-index of Linda T. Vahdat?
ScholarIQi10-index
Linda T. Vahdat has an i10-index of 156 in OpenAlex.
What is the ORCID of Linda T. Vahdat?
ScholarIQorcid
The ORCID for Linda T. Vahdat is on the source record.
What is the OpenAlex record for Linda T. Vahdat?
ScholarIQopenalex
The OpenAlex for Linda T. Vahdat is on the source record.
What are the most-cited papers on Linda T. Vahdat?
ScholarIQmost cited works
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat, Sara M. Tolaney, Steven J. Isakoff, Jennifer R. Diamond, Joyce O’Shaughnessy, Rebecca Moroose, Alessandro D. Santin, Vandana G. Abramson, Nikita Shah, Hope S. Rugo, David M. Goldenberg, Ala M. Sweidan, Robert Iannone, Sarah A. Washkowitz, Robert M. Sharkey, William A. Wegener, Kevin Kalinsky
Randomized Trial of Black Cohosh for the Treatment of Hot Flashes Among Women With a History of Breast Cancer
Judith S. Jacobson, Andrea B. Troxel, Joel M. Evans, Lorissa Klaus, Linda T. Vahdat, David W. Kinne, K. M. Steve Lo, Anne A. Moore, Pamela J. Rosenman, Elizabeth L. Kaufman, Alfred I. Neugut, Victor R. Grann
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Aditya Bardia, Sara M. Tolaney, Kevin Punie, Delphine Loirat, Mafalda Oliveira, Kevin Kalinsky, Amelia Zelnak, Philippe Aftimos, Florence Dalenc, Sagar Sardesai, Erika Hamilton, Priyanka Sharma, Sabela Recalde, Eva Ciruelos Gil, T Traina, Joyce O’Shaughnessy, Javier Cortés, Mu‐Hung Tsai, Linda T. Vahdat, Véronique Dièras, Lisa A. Carey, Hope S. Rugo, David M. Goldenberg, Q. Hong, Martin Olivo, Loretta M. Itri, Sara A. Hurvitz
Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy
Clare Taylor, Dawn L. Hershman, Nina Shah, Nicole Suciu‐Foca, Dan P. Petrylak, Robert N. Taub, Linda T. Vahdat, Bin Cheng, Mark D. Pegram, Keith L. Knutson, Raphael Clynes